Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
Genes associated with T helper 17 cell differentiation and function.
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
215ON201 BIIB033 In Acute Optic Neuritis (AON) (RENEW)
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Headaches in multiple sclerosis: Cross-sectional study of a multiethnic population.
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
Understanding the Metabolic Consequences of Human Arylsulfatase A Deficiency through a Computational Systems Biology Study.
Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.
Avonex approval application
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.
Second International Porto Congress of Multiple Sclerosis
Neuroscience 2014
Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.
Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.
Estrogen and testosterone therapies in multiple sclerosis.
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
American Academy of Neurology 2012 Annual Meeting
Episode 19 with Dr. Samuel Ludwin on treating MS subtypes
The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.

Pages